Brinker Capital’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$1.88M Buy
53,485
+4,667
+10% +$168K 0.06% 318
2020
Q1
$1.59M Buy
48,818
+37,241
+322% +$1.45M 0.06% 287
2019
Q4
$524K Buy
11,577
+2,334
+25% +$97.7K 0.02% 701
2019
Q3
$376K Sell
9,243
-20
-0.2% -$847 0.01% 762
2019
Q2
$398K Sell
9,263
-10,953
-54% -$421K 0.01% 739
2019
Q1
$776K Sell
20,216
-795
-4% -$30.4K 0.03% 547
2018
Q4
$743K Sell
21,011
-1,240
-6% -$45K 0.03% 488
2018
Q3
$857K Sell
22,251
-5,488
-20% -$192K 0.03% 537
2018
Q2
$907K Sell
27,739
-3,357
-11% -$101K 0.03% 512
2018
Q1
$850K Buy
31,096
+4,442
+17% +$121K 0.03% 520
2017
Q4
$661K Buy
26,654
+1,063
+4% +$29.3K 0.03% 598
2017
Q3
$746K Sell
25,591
-800
-3% -$22.1K 0.03% 520
2017
Q2
$732K Buy
26,391
+7,684
+41% +$204K 0.03% 446
2017
Q1
$465K Buy
+18,707
New +$455K 0.02% 620

Other funds holding BSX

Brinker Capital's BSX Position: Q2 2020 in Review

Brinker Capital increased its Boston Scientific (BSX) stake by 9.6% in Q2 2020, buying an estimated $168K and bringing the position to 53,485 shares worth $1.88M. The position accounts for 0.06% of the portfolio, ranked #318.

Brinker Capital first reported a position in BSX in Q1 2017 and has held it in 14 quarters since. 841 funds tracked by Wall St. Rank hold BSX as of Q2 2020.

  • Brinker Capital held 53,485 shares of Boston Scientific worth $1.88M as of Q2 2020.
  • Brinker Capital bought 4,667 Boston Scientific shares in Q2 2020, an estimated $168K.
  • Boston Scientific made up 0.06% of Brinker Capital's portfolio in Q2 2020, its #318 holding.
  • Brinker Capital first reported a position in Boston Scientific in Q1 2017 and has held it in 14 quarters since.
  • 841 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2020.

Based on Brinker Capital's 13F filing for Q2 2020, filed 30 Jul 2020.